Ann
Gruber-Baldini, PhD | Reba
Cornman, MSW
|
W. Gary
Erwin, PharmD
Donald
O. Fedder, BSP, DrPH | Cherokee Layson-Wolf, PharmD
Robert Michocki, PharmD |
C. Daniel Mullins, PhD | Denise Orwig,
PhD
Francis Palumbo, PhD, JD
| Gary
Smith, PharmD
Sheila Weiss,
PhD
C. Daniel
Mullins, PhD

C. Daniel
Mullins, PhD
is
Professor and Chair of the Pharmaceutical Health Services
Research Department at
the University of Maryland - School of Pharmacy. He received his
BS in Economics from M.I.T. and his MA and PhD in Economics from
Duke University. His research and teaching focuses on
pharmacoeconomics, pharmaceutical/health outcomes research,
pharmaceutical pricing, and economic analysis of the
pharmaceutical industry. He is the Shared Resources Core
Director for the NIH-sponsored University of Maryland Center for
Health Disparities Research, Training, and Outreach and is
co-Investigator on several other NIH Health Disparities grants,
where his principal role is evaluating the cost-effectiveness of
interventions aimed at reducing health disparities. He has
designed several cost-effectiveness analyses and budget impact
models for both the pharmaceutical and insurance industries.
He has designed several
cost-effectiveness analyses and budget impact models for both
the pharmaceutical and insurance industries. He is
author/co-author of nearly 100 peer-reviewed articles and book
chapters on pharmacoeconomics, outcomes research, and
pharmaceutical policy and health disparities research in
journals such as The American Journal of Managed Care,
The American Journal of Public Health, Cancer,
Chest, The Journal of Trauma, The Journal of
Managed Care Pharmacy, Pharmacoeconomics, Social
Science & Medicine, and Transplantation. Dr. Mullins
is a member of the Maryland Health Care Commission Hospital and
Ambulatory Surgical Facility Report Card Steering Committee.
Prior to his graduate studies, Dr. Mullins was an Actuary and
Market Researcher for the John Hancock Insurance Company. In
2002, he was the recipient of an Outstanding Service Award from
the Drug Information Association (DIA) and in 2006 he received
an International Society For Pharmacoeconomics and Outcomes
Research (ISPOR) Service Award.